Peapack Gladstone Financial Corp Eli Lilly & CO Transaction History

Peapack Gladstone Financial Corp

$6.94 Billion
Q3 2024

A detailed history of Peapack Gladstone Financial Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Peapack Gladstone Financial Corp holds 73,627 shares of LLY stock, worth $56.5 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares

73,627

Previous 76,942 4.31%

Holding current value

$56.5 Million

Previous $69.7 Million 6.36%

% of portfolio

0.94%

Previous 1.07%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 26, 2024	SELL	$772.14 - $960.02 $2.56 Million - $3.18 Million	-3,315 Reduced 4.31%	73,627 $65.2 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $155,847 - $195,443	-215 Reduced 0.28%	76,942 $69.7 Million
Q1 2024 May 10, 2024	SELL	$592.2 - $792.28 $567,919 - $759,796	-959 Reduced 1.23%	77,157 $60 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $1.91 Million - $2.25 Million	-3,632 Reduced 4.44%	78,116 $45.5 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $183,008 - $252,305	-421 Reduced 0.51%	81,748 $43.9 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $1.97 Million - $2.64 Million	-5,627 Reduced 6.41%	82,169 $38.5 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $1.28 Million - $1.51 Million	-4,129 Reduced 4.49%	87,796 $30.5 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $496,151 - $578,115	-1,543 Reduced 1.65%	91,925 $33.6 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $5.19 Million - $5.91 Million	17,495 Added 23.03%	93,468 $30.2 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $413,914 - $485,995	-1,485 Reduced 1.92%	75,973 $24.6 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $446,615 - $555,028	-1,903 Reduced 2.4%	77,458 $22.2 Million
Q4 2021 Feb 15, 2022	BUY	$224.85 - $279.04 $1.65 Million - $2.05 Million	7,350 Added 10.21%	79,361 $21.9 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $444,308 - $546,783	-2,005 Reduced 2.71%	72,011 $16.6 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $201,313 - $260,397	-1,115 Reduced 1.48%	74,016 $17 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $726,130 - $940,009	4,419 Added 6.25%	75,131 $14 Million
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $589,026 - $779,424	4,515 Added 6.82%	70,712 $11.9 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $1.11 Million - $1.29 Million	-7,622 Reduced 10.33%	66,197 $9.8 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $297,395 - $357,912	-2,180 Reduced 2.87%	73,819 $12.1 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $532,867 - $659,538	-4,476 Reduced 5.56%	75,999 $10.5 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $341,074 - $422,451	-3,190 Reduced 3.81%	80,475 $10.6 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $149,506 - $162,624	-1,400 Reduced 1.65%	83,665 $9.36 Million
Q2 2019 Aug 15, 2019	SELL	$110.79 - $129.32 $24,484 - $28,579	-221 Reduced 0.26%	85,065 $9.43 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $7,346 - $8,647	-66 Reduced 0.08%	85,286 $11.1 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $71,906 - $80,556	-679 Reduced 0.79%	85,352 $9.88 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $775,830 - $969,653	9,036 Added 11.74%	86,031 $9.23 Million
Q2 2018 Aug 09, 2018	BUY	$75.7 - $86.88 $543,904 - $624,232	7,185 Added 10.29%	76,995 $6.57 Million
Q1 2018 May 10, 2018	BUY	$74.21 - $87.6 $142,557 - $168,279	1,921 Added 2.83%	69,810 $0
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $349,392 - $374,762	4,264 Added 6.7%	67,889 $0
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $193,831 - $215,133	2,515 Added 4.12%	63,625 $0
Q2 2017 Aug 14, 2017	BUY	N/A	61,110	61,110 $0

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Peapack Gladstone Financial Corp with notifications on news.

Account

Peapack Gladstone Financial Corp Eli Lilly & CO Transaction History